In an interview with Targeted Oncology, George Mulligan, PhD, discussed the key takeaways from analysis of the Immune Atlas ...

We often treat a DNA result like a final, divine verdict. In a time when truth can feel subjective, a laboratory report has ...

The Ministry of Health says the goal is to transition Sickle Cell Disease (SCD) care from emergency response to consistent, ...

Early results from the ongoing QUILT-106 clinical trial (NCT06334991) show that the treatment combination of CD19 chimeric antigen receptor natural killer (CAR-NK) cells with rituximab (Rituxan) can ...

It was when her symptoms got worse that she went for help ...

As we get older, pain quietly becomes a background feature of life. Aches after the weekend. Stiffness in the morning. A ...

A nurse who was “tired all the time” but put it down to her long shifts discovered it was actually a symptom of a rare cancer ...

In the draft guidance, the agency discusses how sponsors can leverage MRD and complete response rates as near-term efficacy measures and speed new therapies to market.

Amid growing evidence suggesting circadian rhythms play a critical in the safety and efficacy of CAR T-cell therapy, ...

By Dr. Liji Thomas, MD A large prospective study suggests that a routine creatinine blood test may help flag people at higher risk of osteoporosis and fractures, revealing a narrow “sweet spot” where ...

The trial seeks to find an easier and less expensive way to detect a disease that affects 1 in 9 people over the age of 65.